In re Air Cargo Shipping Services Antitrust Litigation – Partial Settlement: Over $750 million in partial settlements for an alleged global conspiracy to fix surcharges for air cargo shipping services.
In re Automotive Parts Antitrust Class Action: Involving alleged price-fixing conspiracies as to various automotive parts that are components of new motor vehicles. Partial settlement to date of $4.56 million.
In re Polyurethane Foam Antitrust Litigation: $9 million in partial settlements regarding an alleged conspiracy to unlawfully fix the prices of polyurethane foam in the United States.
In re Imprelis Herbicide Marketing, Sales Practices and Products Liability Litigation: Involving alleged misrepresentations by DuPont regarding the safety of and environmental damage resulting from use of Imprelis herbicide. (Prior to joining Robins, Kaplan, Miller & Ciresi L.L.P.)
In re Lorazepam and Clorazepate Antitrust Litigation: $135.4 million settlement for claims that Mylan Laboratories, Inc. implemented unlawful and anticompetitive price increases for generic versions of the anti-anxiety drugs Lorazepam and Clorazepate. (Prior to joining Robins, Kaplan, Miller & Ciresi L.L.P.)
In re Abbott Laboratories Norvir Antitrust Litigation: $10 million settlement stemming from Abbott Laboratories’ price increase of Norvir, which provides for a payment to non-profit organizations serving individuals with HIV. (Prior to joining Robins, Kaplan, Miller & Ciresi L.L.P.)
In re Marine Hose Antitrust Litigation: $32 million settlement on behalf of businesses injured by an alleged conspiracy to fix the prices of marine hose. (Prior to joining Robins, Kaplan, Miller & Ciresi L.L.P.)
In re Puerto Rican Cabotage Antitrust Litigation: $52 million settlement for an alleged conspiracy to fix the prices of ocean freight services between the continental United States and Puerto Rico. (Prior to joining Robins, Kaplan, Miller & Ciresi L.L.P.)
In re Brand Name Prescription Drug Indirect Purchaser Antitrust Litigation: Ms. Salzman was principally responsible for administering a $65 million multi-state settlement to community health centers for subsidizing prescriptions to low-income patients on behalf of retail pharmacies for alleged price discrimination by pharmaceutical manufacturers. (Prior to joining Robins, Kaplan, Miller & Ciresi L.L.P.)